Navigation Links
IPS and G-CON Launch iCON Cell Therapy Facility Platform
Date:9/7/2018

Following up on the launch of the iCON Turnkey Facility Platform for a mAb manufacturing facility late last year, IPS-Integrated Project Services, LLC and G-CON Manufacturing have successfully designed and delivered the first ÜBERcellFLEX PODs for the manufacturing of autologous cell therapies. The iCON solution provides a pre-fabricated modular cleanroom infrastructure for the drug manufacturers’ requirements for both clinical and commercial manufacture of critical therapies. Following the iCON model, IPS provided the engineering design while G-CON built, tested and delivered the ÜBERcellFLEX CAR-T processing suites in both twelve (12) foot and twenty-four (24) foot wide POD configurations.

“This is an exciting time for our companies as the iCON platform is being adopted by clients who recognize that new innovative approaches are needed to meet the growing demand for cell and gene therapy manufacturing” said Dennis Powers, Vice President of Business Development and Sales Engineering at G-CON Manufacturing Inc. “We believe that the iCON platform approach with its faster and more predictable project schedules for new facility construction are essential for supplying life changing therapies to the patients that need them.”

“The gene therapy industry needs standardized solutions to meet its speed to market requirements,” said Tom J. Piombino, Vice President & Process Architect at IPS. “In addition to our larger 2K mAb facility platform that we rolled out earlier this year, the ÜBERcellFLEX12 and 24 represent a line of gene/cell therapy products that operating companies can buy today, ready-to-order, in either an open or closed-processing format with little to no engineering time – we start fabricating almost immediately after URS alignment. Multiple cellFLEX units can be installed to scale up/out from Phase 1 Clinical production to Commercial Manufacturing and serve the needs of thousands of CAR-T patients per year. Being able to meet this critical need is consistent with our vision; we’re thrilled to be able to offer this modular solution to help our clients get therapies to their patients.”

About iCON
The iCON platform, the collaborative efforts of IPS and G-CON Manufacturing, Inc., is redefining facility project execution for the biopharma industry where there is a growing need for more rapidly deployable and flexible manufacturing capability. iCON has launched turnkey designs for monoclonal antibody facilities and autologous cell therapies, and is developing platforms for cell and gene therapies, vaccines, OSD, and aseptic filling. An iCON solution can be deployed for:

  • Greenfield Application: Under an EPCMV format, IPS and G-CON Manufacturing deliver a turnkey facility through IOQ, from foundations up.
  • Interior Fit-Out Application: Under an EPCMV format, IPS and G-CON Manufacturing deliver a turnkey facility through IOQ utilizing an existing facility or shell.
  • Manufacturing Cleanroom Application: Under a vendor subcontract format, IPS and G-CON Manufacturing deliver offsite prefabricated cleanroom modules for the classified manufacturing areas (either our standard ÜBERFLEX line or custom designs) with the 3rd party process equipment train and qualification being optional.
  • Custom Applications: Non-standard products or hybrid versions of any of the above.

About G-CON
G-CON Manufacturing designs, produces and installs prefabricated cleanroom PODs®. G-CON’s cleanroom POD portfolio encompasses a variety of different dimensions and purposes, from laboratory environments to personalized medicine and production process platforms. The POD cleanroom units are unique from traditional cleanroom structures due to the ease of scalability, mobility and the ability to repurpose the PODs once the production process reaches the end of its lifecycle. For more information, please visit the Company's website at http://www.gconbio.com.

About IPS
IPS is a global leader in developing innovative facility and bioprocess solutions for the biotechnology and pharmaceutical industries. Through operational expertise and industry-leading knowledge, skill and passion, IPS provides consulting, architecture, engineering, construction management, and compliance services that allow clients to create and manufacture life-impacting products around the world. Headquartered in Blue Bell, PA-USA, IPS is one of the largest multi-national companies servicing the life sciences industry with over 1,100 professionals in the US, Canada, Brazil, UK, Ireland, Switzerland, Singapore, China, and India. Visit our website at http://www.ipsdb.com.

Read the full story at https://www.prweb.com/releases/ips_and_g_con_launch_icon_cell_therapy_facility_platform/prweb15738605.htm.


'/>"/>
Source: PRWeb
Copyright©2018 Vocus, Inc.
All rights reserved


Related biology news :

1. A start-up at NJIT develops bleeding-control gel for brain surgery
2. BellBrook Labs Launches New Streamlined Website
3. Advances in 3-D Printing Launch a Promising Future for Birth Defects Treatments
4. GCE Launches Groundbreaking New Product: Shadow
5. Delta launches biometrics to board aircraft at Reagan Washington National Airport
6. Istituto Italiano di Tecnologia (IIT) and Movendo Technology Launch the Production of their First 30 Rehabilitative Hunova Robots
7. Allen Cell Explorer Launched
8. PMD Launches New Device and Digital Health Platform
9. Newly Launched Identity Strategy Partners, LLP Provides Policy and Technical Consultation on Complex Identity Issues to the Private and Public Sectors
10. higi Launches New Partnership Initiative with National Brands, Thought-Leaders and Celebrities
11. LegacyXChange Releases First Teaser Video Highlighting the Benefits of Its Soon to be Launched Site to the $5 Billion Worldwide Sports Collectibles Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/13/2019)... ... June 13, 2019 , ... Global ... exclusively serving the end-to-end clinical and ancillary supply chain management needs of large- ... medical research organizations, today announced it will sponsor a summer education program offered ...
(Date:6/11/2019)... WEST LAFAYETTE, Ind. (PRWEB) , ... June 10, 2019 , ... ... Synchrotron Methods” in the July 2019 issue of AAPS PharmSciTech. The article was published ... A. Smith of Improved Pharma, along with Xiaoming Sean Chen of Purdue University. ...
(Date:6/6/2019)... (PRWEB) , ... June 05, 2019 , ... ... announces the opening of a new network station and service center in Mexico ... and 12th in the world — with more than $1.75 billion in pharmaceutical ...
Breaking Biology News(10 mins):
(Date:6/11/2019)... ... 11, 2019 , ... Veterinary Regenerative Medicine company, VetStem ... announced that their GMP facility for cell production is now approved by the ... is an important milestone for VetStem as it expands into contract cell manufacturing ...
(Date:5/31/2019)... ... May 30, 2019 , ... World Compliance Seminars today ... 08-09, 2019 in Boston, MA. This peer recommended interactive workshop is always selected ... training will kick off with a compendial treatment of Data Integrity fundamentals. After ...
(Date:5/15/2019)... ... May 15, 2019 , ... Milton Hershey School® has named ... his work within the biomedical industry, where he is changing lives by creating solutions ... , “William Harding epitomizes the vision of our founders – Milton and Catherine Hershey ...
(Date:5/7/2019)... ... May 06, 2019 , ... "The new Liquid Nitrogen Best ... being asked to store cellular products being used in adoptive therapy research ... world leaders, who have shared their expertise in building and managing facilities to ...
Breaking Biology Technology: